12 Health Care Stocks Moving In Friday's Intraday Session
Nuwellis Inc NUWE
$0.75
βΌ -1.88%
($-0.01)
⬇️ Below Yest. Low
🔥 High Short Interest
🎈 Low Float
Open
$0.76
Prev Close
$0.76
Day Range
$0.73 β $0.77
52W Range
$0.71 β $172.90
Market Cap
$2.72M
Beta
0.11
EPS (TTM)
$-136.17
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2012-02-16 |
| Shares Out. | 510,000 |
| Website | nuwellis.com/ β |
| Phone | 18009279800 |
| Employees | 38 |
| Revenue | $2.0M |
| Gross Profit | $1.5M |
| Net Income | -$4.8M |
| Free Cash Flow | -$12.6M |
| Total Assets | $9.1M |
| Total Liabilities | $11.2M |
| Equity | -$2.1M |
About Nuwellis Inc
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Nuwellis Inc is a publicly traded company under the ticker symbol NUWE on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
6 analysts (2026-09-01)
π° Latest News for NUWE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Nuwellis Reports 31 Aquadex Console Sales in 2026, Expanding Recurring Revenue Opportunity
12 Health Care Stocks Moving In Thursday's Intraday Session
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs

